C.CAS MANCHA efectua el pago de 38,75 euros por los intereses de su emision ES0001350125
How ‚quiet luxury‘ is subtly taking over investor portfolios
Quiet luxury was one of last year’s biggest viral fashion trends, but unlike other short-lived fads, this one has made its way into investor portfolios.
Busy Fed week, tech earnings could dictate the course of this rally, Fundstrat’s Tom Lee says
Tom Lee was calling for new highs by late January, but an air pocket may be forming.
IMF upgrades global growth forecast, citing U.S. resilience and policy support in China
The International Monetary Fund sees a reduced likelihood of a so-called „hard landing,“ with inflation falling faster than expected.
Stocks are the ‚asset class of choice‘ as markets are now used to bad news, strategist says
Stocks are still the „asset class of choice“ even as geopolitical risks mount, says Beat Wittmann, partner at Porta Advisors.
Alibaba-backed Xreal, rival to Apple’s Vision Pro, claims it’s now an AR glasses unicorn
Alibaba-backed augmented reality glasses company Xreal said it received $60 million in new funding, giving the company a valuation of more than $1 billion.
Workers are sour on the job market — but it may not be warranted
Layoffs and unemployment remain quite low by historical standards. So why do workers still feel lousy?
Having too many options can paralyze investors. Here’s how you can overcome ‚choice overload‘
Having too much choice can paralyze good investment decisions via „choice overload.“
Pfizer beats earnings estimates as declining Covid business loses less revenue than expected
Pfizer reversed roughly $3.5 billion in revenue related to the expected return of 6.5 million doses of its Covid drug, Paxlovid, from the U.S. government.